249 related articles for article (PubMed ID: 2299764)
1. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
Kernodle DS; Classen DC; Burke JP; Kaiser AB
JAMA; 1990 Feb; 263(7):961-6. PubMed ID: 2299764
[TBL] [Abstract][Full Text] [Related]
2. Which cephalosporin for wound prophylaxis? An experimental comparison of three drugs.
Scher KS; Jones CW
Surgery; 1985 Jul; 98(1):30-4. PubMed ID: 3892746
[TBL] [Abstract][Full Text] [Related]
3. Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors.
Edwards WH; Kaiser AB; Tapper S; Edwards WH; Martin RS; Mulherin JL; Jenkins JM; Roach AC
J Vasc Surg; 1993 Sep; 18(3):470-5; discussion 475-6. PubMed ID: 8377241
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.
Maki DG; Bohn MJ; Stolz SM; Kroncke GM; Acher CW; Myerowitz PD
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1423-34. PubMed ID: 1434726
[TBL] [Abstract][Full Text] [Related]
5. Correlation of in-vitro parameters of antimicrobial activity with prophylactic efficacy in an intradermal model of Staphylococcus aureus infection.
Warren MD; Kernodle DS; Kaiser AB
J Antimicrob Chemother; 1991 Nov; 28(5):731-40. PubMed ID: 1778876
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cefamandole and cefazolin during cardiopulmonary bypass.
Bryan CS; Smith CW; Sutton JP; Allen WB; Blanding R; Gangemi JD
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):222-5. PubMed ID: 6348425
[TBL] [Abstract][Full Text] [Related]
7. Surgical prophylaxis: how far have we really come?
Kernodle DS
Pharmacotherapy; 1988; 8(6 Pt 2):11S-13S. PubMed ID: 3075742
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients.
Kaiser AB; Petracek MR; Lea JW; Kernodle DS; Roach AC; Alford WC; Burrus GR; Glassford DM; Thomas CS; Stoney WS
Ann Surg; 1987 Dec; 206(6):791-7. PubMed ID: 3689015
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection.
Kernodle DS; Voladri RK; Kaiser AB
J Infect Dis; 1998 Mar; 177(3):701-6. PubMed ID: 9498450
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin.
Gentry LO; Zeluff BJ; Cooley DA
Ann Thorac Surg; 1988 Aug; 46(2):167-71. PubMed ID: 3401076
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
Wiktorowicz-Belzyt E; Wojak I; Janicka G
Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
[TBL] [Abstract][Full Text] [Related]
12. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections.
Kernodle DS; Classen DC; Stratton CW; Kaiser AB
J Clin Microbiol; 1998 Jan; 36(1):219-22. PubMed ID: 9431951
[TBL] [Abstract][Full Text] [Related]
13. Use of cefazolin microspheres to treat localized methicillin-resistant Staphylococcus aureus infections in rats.
Fallon MT; Shafer W; Jacob E
J Surg Res; 1999 Sep; 86(1):97-102. PubMed ID: 10452874
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis in open-heart surgery patients: comparison of cefamandole and cefuroxime.
Peterson CD; Lake KD; Arom KV; Love KR
Drug Intell Clin Pharm; 1987 Sep; 21(9):728-32. PubMed ID: 3498617
[TBL] [Abstract][Full Text] [Related]
17. Cefuroxime versus cefazolin as prophylaxis in vascular surgery.
Edwards WH; Kaiser AB; Kernodle DS; Appleby TC; Edwards WH; Martin RS; Mulherin JL; Wood CA
J Vasc Surg; 1992 Jan; 15(1):35-41; discussion 41-2. PubMed ID: 1728688
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
[TBL] [Abstract][Full Text] [Related]
19. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery.
Schweizer ML; Chiang HY; Septimus E; Moody J; Braun B; Hafner J; Ward MA; Hickok J; Perencevich EN; Diekema DJ; Richards CL; Cavanaugh JE; Perlin JB; Herwaldt LA
JAMA; 2015 Jun; 313(21):2162-71. PubMed ID: 26034956
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus.
Dodds Ashley ES; Carroll DN; Engemann JJ; Harris AD; Fowler VG; Sexton DJ; Kaye KS
Clin Infect Dis; 2004 Jun; 38(11):1555-60. PubMed ID: 15156442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
